Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesApr 23, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesApr 12, 2013View HTMLDownload DOCDownload PDF
ARSAn annual report to security holders.Apr 8, 2013View HTMLDownload DOCDownload PDF
DEF 14AOfficial notification to shareholders of matters to be brought to a vote ("Proxy")Apr 5, 2013View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveApr 5, 2013View HTMLDownload DOCDownload PDFDownload XLS
CT ORDERConfidential treatment orderApr 2, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 28, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 27, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 26, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 20, 2013View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventMar 18, 2013View HTMLDownload DOCDownload PDFDownload XLS
8-KReport of unscheduled material events or corporate eventMar 18, 2013View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesMar 8, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 6, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 6, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesMar 4, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesFeb 28, 2013View HTMLDownload DOCDownload PDF
10-KAnnual report which provides a comprehensive overview of the company for the past yearFeb 26, 2013View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
4Statement of changes in beneficial ownership of securitiesFeb 26, 2013View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-153

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information